References
- Brock M. H., Dansereau R. J., Patel V. S. Use of in vitro and in vivo data in the design, development, and quality control of sustained–release decongestant dosage forms. Pharmacotherapy 1994; 14: 430–437
- Drewe J., Guitard P. In vitro/in vivo correlation for modified‐release formulations. J. Pharm. Sci. 1993; 82: 132–137
- Uppor V. R. Regulatory perspectives in in vitro (Dissolution) in vivo (bioavailability) correlations. J. Control. Release 2001; 72: 127–132
- Murthy K. S., Ghebre‐Sellassie I. Current perspectives on the dissolution stability of solid oral dosage forms. J. Pharm. Sci. 1993; 82: 113–126
- Quist P. O., Ostling G. Accelerated dissolution testing for improved quality assurance. J. Pharm. Biomed. Anal. 2002; 28: 1081–1089
- Qureshi S. A., McGilvery I. J. Assessment of pharmaceutical quality of furosemide tablets from multinational markets. Drug Dev. Ind. Pharm. 1998; 24: 995–1005
- Dressman J. B., Reppas C. In vitro in vivo correlation for lipophilic, poorly water‐soluble drugs. Eur. J. Pharm. Sci. 2000, Suppl 2: S73–S80
- Rostami‐Hodjegan A., Shira M. R., Tucker G. T., Conway B. R., Irwin W. J., Shaw L. R., Grattan T. J. A new rapidly absorbed paracetamol tablet containing sodium bicarbonate. II. Dissolution studies and in vitro/in vivo correlation. Drug Dev. Ind. Pharm. 2002; 28: 533–543
- Kortejarvi H., Mikkola J., Backman M., Antila S., Marvola M. Development of level A, B, and C in vitro in vivo correlation for modified‐release levosimendan capsule. Int. J. Pharm. 2002; 24: 87–95
- Roshdy M. N., Schnaare R. L., Sugita E. T., Zietz S., Schwartz J. B. An adjusted pharmacokinetic equation for predicting drug levels in vivo based on in vitro square root of time release kinetics. Pharm. Dev. Technol. 2002; 203–213
- Roshdy M. N., Schnaare R. L., Sugita E. T., Schwartz J. B. The effect of controlled release tablet performance and hydrogel strength on in vitro/in vivo correlation. Pharm. Dev. Technol. 2002; 7: 155–168
- Horter D., Dressman J. B. Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. Adv. Drug Deliv. Rev. 2001; 46: 75–87
- Dali M. V., Carstensen J. T. Particle size distribution from multi‐particulate dissolution. Drug Dev. Ind. Pharm. 1998; 24: 637–644
- Shah V. P., Gurbarg M., Noory A., Dighe S., Skelly J. P. Influence of higher rates of agitation on release patterns of immediate‐release drug products. J. Pharm. Sci. 1992; 81: 500–5003
- Kamba M., Seta Y., Takeda N., Hamaura T., Kusai A., Nakane H., Nishimura K. Measurement of agitation force in dissolution test and mechanical destructive force in disintegration test. Int. J. Pharm. 2003; 250: 99–109
- Morihara M., Aoyaji N., Kaniwa N., Katori N., Kojim S. Hydrodynamic flow around tablets in different pharmacopeial dissolution tests. Drug Dev. Ind. Pharm. 2002; 28: 655–662
- Underwood F. L., Cadwallader D. E. Effects of various hydrodynamic conditions on dissolution rate determinations. J. Pharm. Sci. 1976; 65: 697–700
- Cartensen J. T., Dali M. Determination of mass transfer dissolution rate constants from critical time of dissolution of a powder sample. Pharm. Dev. Technol. 1999; 4: 1–8
- Healy A. M., McCarthy L. G., Gallagher K. M., Corrigan O. I. Sensitivity of dissolution rate to location in the paddle dissolution apparatus. J. Pharm. Pharmacol. 2002; 54: 441–444
- Pillay Y., Fassihi R. Evaluation and comparison of dissolution data derived from different modified release dosage forms: an alternative method. J. Control. Release 1998; 55: 45–55
- Bhattachar S. N., Wesley J. A., Fioritto A., Martin P. J., Babu S. R. Dissolution testing of poorly soluble compound using the flow‐through cell dissolution apparatus. Int. J. Pharm. 2002; 236: 135–143
- Cappola M. L. A better dissolution method for ranitidine tablets USP. Pharm. Dev. Technol. 2001; 6: 11–17
- Shaw L. R., Irwin W. J., Grattan T. J., Conway B. R. The development of a modified dissolution method suitable for investigating powder mixtures. Drug Dev. Ind. Pharm. 2002; 28: 1147–1153
- Mulder H., Brere A. M., Van Adel J. G., Rulkens W. H. Influence of hydrodynamic conditions on napthalene dissolution and subsequent biodegradation. Biotechnol. Bioeng. 1998; 57: 145–154
- Grassi M., Colombo I., Lapasin R. Experimental determination of the theophylline diffusion coefficient in swollen sodium‐alginate membranes. J. Control. Release 2001; 76(1–2)93–105
- Pade V., Stavchansky S. Estimation of the relative contribution of the transcellular and paracellular pathway to the transport of passively absorbed drug in the Caco‐2 cell culture model. 1997; 14(9)1210–1215